Back to search
Kaposiform Hemangioendothelioma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Kaposiform Hemangioendothelioma trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Kaposiform Hemangioendothelioma trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This randomized clinical trial evaluates if low-dose sirolimus (target trough 4-8 ng/mL) combined with prednisolone is noninferior in efficacy but superior in s…
Lymphatic anomalies are a rare subset of vascular anomalies that are poorly understood. the understanding of the natural history, long-term outcomes, risk facto…
To research and explore the antibody protection and immune memory after vaccination in children with KHE during sirolimus administration. To explore the feasibi…
The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest pro…
The purpose of this study is to determine if the use of sirolimus in the treatment of children and young adults with complicated vascular anomalies will prove t…
Sirolimus has demonstrated efficacy in the treatment of kaposiform hemangioendothelioma (KHE); however, a high rate of rebound growth following discontinuation…